Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950123-01-002716
Filing Date
2001-03-28
Accepted
2001-03-28 00:00:00
Documents
14
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 PFIZER INC. y46668e10-k405.htm 10-K405 230894
2 SUMMARY OF ANNUAL INCENTIVE PLAN y46668ex10-20.htm EX-10.20 1191
3 EMPLOYMENT AGREEMENT RE: PETER B. CORR y46668ex10-23.htm EX-10.23 3866
4 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES y46668ex12.htm EX-12 16824
5 THE 2000 ANNUAL REPORT y46668ex13-a.htm EX-13.A 841695
6 SUBSIDIARIES OF THE COMPANY y46668ex21.htm EX-21 96549
7 CONSENT OF KPMG LLP y46668ex23-1.htm EX-23.1 5336
8 CONSENT AND OPINION OF PRICEWATERHOUSECOOPERS LLP y46668ex23-2.htm EX-23.2 3073
9 y46668y4666840a.jpg GRAPHIC 15147
10 y46668y4666840b.jpg GRAPHIC 13667
11 y46668y4666840c.jpg GRAPHIC 11179
12 y46668y4666840d.jpg GRAPHIC 3455
13 y46668y4666841a.jpg GRAPHIC 4749
14 y46668y4666841b.jpg GRAPHIC 2007
  Complete submission text file 0000950123-01-002716.txt   1252676
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-03619 | Film No.: 1581077
SIC: 2834 Pharmaceutical Preparations